{"entity":{"type":"insider","cik":"0001674006","url":"/insider/0001674006","json_url":"/insider/0001674006.json","name":"Sooch Mina","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":3,"first":"2016-08-12","last":"2022-05-23","span_basis":"filed_date"},"name_variants":[{"name":"Sooch Mina","source":"filing","n_filings":3,"first_seen":"2016-08-12","last_seen":"2022-05-23"}],"transactions":[{"id":6692100,"accession":"0001140361-22-020274","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-020274","line_url":"/filing/0001140361-22-020274#line-2","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"Ocuphire Pharma, Inc.","issuer_ticker":"OCUP","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001674006","owner_name":"Sooch Mina","owner_display_name":"Sooch Mina","owner_url":"/insider/0001674006","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":2.024,"price_display":"2.02","price_state":"stated","total_value":25300.0,"total_display":"25,300.00","total_whole":"25,300","shares_owned_after":425022.0,"shares_owned_after_display":"425,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-23","scope":"insider"},{"id":6692096,"accession":"0001140361-22-020274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-020274","line_url":"/filing/0001140361-22-020274#line-1","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"Ocuphire Pharma, Inc.","issuer_ticker":"OCUP","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001674006","owner_name":"Sooch Mina","owner_display_name":"Sooch Mina","owner_url":"/insider/0001674006","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":2.0703,"price_display":"2.07","price_state":"stated","total_value":25878.75,"total_display":"25,878.75","total_whole":"25,879","shares_owned_after":412522.0,"shares_owned_after_display":"412,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-23","scope":"insider"},{"id":2867415,"accession":"0001140361-20-026646","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-20-026646","line_url":"/filing/0001140361-20-026646#line-1","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"Ocuphire Pharma, Inc.","issuer_ticker":"OCUP","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001674006","owner_name":"Sooch Mina","owner_display_name":"Sooch Mina","owner_url":"/insider/0001674006","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11524.0,"shares_display":"11,524","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":800044.0,"shares_owned_after_display":"800,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-19","filed_date":"2020-11-25","scope":"insider"},{"id":2650607,"accession":"0001104659-16-139269","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-139269","line_url":"/filing/0001104659-16-139269#line-4","is_derivative":false,"issuer_cik":"0001638287","issuer_name":"Gemphire Therapeutics Inc.","issuer_ticker":"GEMP","issuer_name_source":null,"issuer_url":"/issuer/0001638287","owner_cik":"0001674006","owner_name":"Sooch Mina","owner_display_name":"Sooch Mina","owner_url":"/insider/0001674006","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52500.0,"shares_display":"52,500","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":525000.0,"total_display":"525,000.00","total_whole":"525,000","shares_owned_after":693732.0,"shares_owned_after_display":"693,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-10","filed_date":"2016-08-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001228627","name":"Ocuphire Pharma, Inc.","url":"/issuer/0001228627","role":"Director, Officer (President and CEO)","n_filings":2,"first_seen":"2020-11-25","last_seen":"2022-05-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001638287","name":"Gemphire Therapeutics Inc.","url":"/issuer/0001638287","role":"Director, Officer (President & CEO)","n_filings":1,"first_seen":"2016-08-12","last_seen":"2016-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001674006","retrieved_at":"2026-08-27T00:37:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}